Performance of LI-RADS category 5 vs combined categories 4 and 5: a systemic review and meta-analysis
- PMID: 38809263
- DOI: 10.1007/s00330-024-10813-5
Performance of LI-RADS category 5 vs combined categories 4 and 5: a systemic review and meta-analysis
Abstract
Objective: Computed tomography (CT)/magnetic resonance imaging (MRI) Liver Imaging Reporting and Data System (LI-RADS, LR) category 5 has high specificity and modest sensitivity for diagnosis of hepatocellular carcinoma (HCC). The purpose of this study was to compare the diagnostic performance of LR-5 vs combined LR-4 and LR-5 (LR-4/5) for HCC diagnosis.
Methods: MEDLINE and EMBASE databases through January 03, 2023 were searched for studies reporting the performance of LR-5 and combined LR-4/5 for HCC diagnosis, using CT/MRI LI-RADS version 2014, 2017, or 2018. A bivariate random-effects model was used to calculate the pooled per-observation diagnostic performance. Subgroup analysis was performed based on imaging modalities and type of MRI contrast material.
Results: Sixty-nine studies (15,108 observations, 9928 (65.7%) HCCs) were included. Compared to LR-5, combined LR-4/5 showed significantly higher pooled sensitivity (83.0% (95% CI [80.3-85.8%]) vs 65.7% (95% CI [62.4-69.1%]); p < 0.001), lower pooled specificity (75.0% (95% CI [70.5-79.6%]) vs 91.7% (95% CI [90.2-93.1%]); p < 0.001), lower pooled positive likelihood ratio (3.60 (95% CI [3.06-4.23]) vs 6.18 (95% CI [5.35-7.14]); p < 0.001), and lower pooled negative likelihood ratio (0.22 (95% CI [0.19-0.25]) vs 0.38 (95% CI [0.35-0.41]) vs; p < 0.001). Similar results were seen in all subgroups.
Conclusions: Our meta-analysis showed that combining LR-4 and LR-5 would increase sensitivity but decrease specificity, positive likelihood ratio, and negative likelihood ratio. These findings may inform management guidelines and individualized management.
Clinical relevance statement: This meta-analysis estimated the magnitude of changes in the sensitivity and specificity of imaging criteria when LI-RADS categories 4 and 5 were combined; these findings can inform management guidelines and individualized management.
Key points: There is no single worldwide reporting system for liver imaging, partly due to regional needs. Combining LI-RADS categories 4 and 5 increased sensitivity and decreased specificity and positive and negative likelihood ratios. Changes in the sensitivity and specificity of imaging criteria can inform management guidelines and individualized management.
Keywords: Computed tomography; Contrast media; Diagnosis; Liver neoplasms; Magnetic resonance imaging.
© 2024. The Author(s), under exclusive licence to European Society of Radiology.
Similar articles
-
Liver Imaging Reporting and Data System version 2018 category 5 for diagnosing hepatocellular carcinoma: an updated meta-analysis.Eur Radiol. 2024 Mar;34(3):1502-1514. doi: 10.1007/s00330-023-10134-z. Epub 2023 Sep 1. Eur Radiol. 2024. PMID: 37656177
-
Diagnostic performance of CT versus MRI Liver Imaging Reporting and Data System category 5 for hepatocellular carcinoma: a systematic review and meta-analysis of comparative studies.Eur Radiol. 2022 Oct;32(10):6723-6729. doi: 10.1007/s00330-022-08985-z. Epub 2022 Jul 18. Eur Radiol. 2022. PMID: 35849177
-
Diagnostic Performance of CT/MRI Liver Imaging Reporting and Data System v2017 for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.Liver Int. 2020 Jun;40(6):1488-1497. doi: 10.1111/liv.14424. Epub 2020 Mar 19. Liver Int. 2020. PMID: 32145134
-
CT and MRI Liver Imaging Reporting and Data System Version 2018 for Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis.J Am Coll Radiol. 2020 Oct;17(10):1199-1206. doi: 10.1016/j.jacr.2020.06.005. Epub 2020 Jul 5. J Am Coll Radiol. 2020. PMID: 32640250
-
Diagnostic performance of CT/MRI LI-RADS v2018 in non-cirrhotic steatotic liver disease.Eur Radiol. 2024 Dec;34(12):7622-7631. doi: 10.1007/s00330-024-10846-w. Epub 2024 Jul 1. Eur Radiol. 2024. PMID: 38951191
Cited by
-
Correlation of Spectral CT-Based Iodine Concentration Parameters with LI-RADS Classification of Suspected Hepatocellular Carcinoma Nodules in Cirrhotic Patients.Diagnostics (Basel). 2025 Mar 14;15(6):725. doi: 10.3390/diagnostics15060725. Diagnostics (Basel). 2025. PMID: 40150069 Free PMC article.
References
-
- Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249 - PubMed
-
- Tang A, Cruite I, Mitchell DG, Sirlin CB (2018) Hepatocellular carcinoma imaging systems: why they exist, how they have evolved, and how they differ. Abdom Radiol (NY) 43:3–12 - PubMed
-
- Lee S, Kim YY, Shin J et al (2023) Percentages of hepatocellular carcinoma in LI-RADS categories with CT and MRI: a systematic review and meta-analysis. Radiology 307:e220646 - PubMed
-
- van der Pol CB, Lim CS, Sirlin CB et al (2019) Accuracy of the liver imaging reporting and data system in computed tomography and magnetic resonance image analysis of hepatocellular carcinoma or overall malignancy—a systematic review. Gastroenterology 156:976–986 - PubMed
-
- Lee S, Kim YY, Shin J et al (2020) CT and MRI liver imaging reporting and data system version 2018 for hepatocellular carcinoma: a systematic review with meta-analysis. J Am Coll Radiol 17:1199–1206 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical